Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06744673 · ClinicalTrials.gov registry record
A Study to Assess the Pregnancy Outcome in Women Exposed to Dayvigo® During Pregnancy Compared to an Unexposed Control Population
A clinical trial of Pregnancy and Sleep Initiation and Maintenance Disorders, sponsored by Eisai.
- Active
- Registry status
- 861
- Enrollment target
- 1
- Study location
NCT06744673 is a study of Pregnancy and Sleep Initiation and Maintenance Disorders that is active but no longer recruiting, run by Eisai. The registered enrollment target is 861 participants, roughly in line with the 868-participant average among 191 other Pregnancy trials with a reported enrollment target. The trial reports 1 study location across 1 state.
The verdict
NCT06744673, a study of Pregnancy and Sleep Initiation and Maintenance Disorders, is active but no longer recruiting, sponsored by Eisai.
- ACTIVE NOT RECRUITING
- Registry status
- 861 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary purpose of the study is to compare the occurrence of major congenital malformations (MCMs) among live births between women with insomnia who are exposed to Dayvigo during the 1st trimester of pregnancy and women with insomnia who are not exposed to any prescription insomnia drugs at any time during the pregnancy and to compare the occurrence of MCMs among live births between women with insomnia who are exposed to Dayvigo during the 1st trimester of pregnancy and women with insomnia who are exposed to a prescription insomnia drug other than Dayvigo during the 1st trimester of pregnancy.
Conditions Studied
Interventions
- OTHER No Intervention
Study Locations (1)
New Jersey
- Eisai Trial Site #1 - Nutley
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 861 participants |
| Start Date | 2025-01-03 |
| Est. Completion | 2025-12-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06744673
The ClinicalTrials.gov registry entry for NCT06744673 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 861 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 868-participant average among 191 other Pregnancy trials with a reported enrollment target. The listed sponsor is Eisai, which has 287 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Pregnancy appearing as the primary indexed condition, and to 1 intervention - of which No Intervention is the first listed.
NCT06744673 reports 1 study location spanning 1 distinct geographic area - top geographies include New Jersey.
Frequently Asked Questions
What is clinical trial NCT06744673 about?
NCT06744673 is a clinical study titled "A Study to Assess the Pregnancy Outcome in Women Exposed to Dayvigo® During Pregnancy Compared to an Unexposed Control Population". The primary purpose of the study is to compare the occurrence of major congenital malformations (MCMs) among live births between women with insomnia who are exposed to Dayvigo during the 1st trimester of pregnancy and women with insomnia who are not exposed to any prescription insomnia drugs at any ...
What is the current status of trial NCT06744673?
This trial is currently active not recruiting. The enrollment target is 861 participants. The study started on 2025-01-03. Estimated completion is 2025-12-30.
What conditions does trial NCT06744673 study?
This clinical trial studies the following conditions: Pregnancy, Sleep Initiation and Maintenance Disorders.
What interventions are being tested in trial NCT06744673?
The interventions under investigation include: No Intervention (OTHER).
Who is sponsoring clinical trial NCT06744673?
This trial is sponsored by Eisai, which has 287 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06744673 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pregnancy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Stelara and Tremfya Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy Project
RECRUITING
-
CGM Adherence Compared to Finger-stick Glucose Monitoring in Pregnancies With Type 2 Pregestational Diabetes
RECRUITING · NA
-
Healthy Start: Exploring the Fuel-mediated Programming of Neonatal Growth
RECRUITING
-
Cocooned Moms Study
RECRUITING · NA
-
Retinal Vascular Changes During Pregnancy
RECRUITING
-
CGM for Management of Type 2 Diabetes in Pregnancy
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.